Home » Topics » Briefs » Other news to note

Other news to note
RSS

Hikma closes acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane

March 2, 2016

FDA announces new Orphan Products Natural History Grants program

March 2, 2016

Alexza Pharmaceuticals and Ferrer enter into a non-binding letter of intent

March 1, 2016

Teva to begin strategic corporate identity program to build global brand

Feb. 26, 2016

Merus acquires rights in France to four launched drugs from Sanofi

Feb. 25, 2016

Sanofi to return U.S. and Canadian rights for Auvi-Q to kaleo

Feb. 24, 2016

Unilife and Amgen establish strategic collaboration for injectable drug delivery systems

Feb. 23, 2016

PeptiDream and JCR Pharmaceuticals sign joint research agreement

Feb. 23, 2016

The University of Tokyo and Sanofi KK sign strategic partnership agreement

Feb. 22, 2016

Lightlake Therapeutics changes its name to Opiant Pharmaceuticals

Feb. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...